FDA's OK Lets Bausch & Lomb Join Eye-Laser Price War

The Food and Drug Administration has approved Bausch & Lomb's (BOL Quote) Technolas 217 Excimer Laser System, bringing another corrective eye surgery laser machine into a highly competitive market currently engaged in a price war.

Bausch & Lomb said it would immediately begin marketing Technolas 217 in the U.S., selling the laser at a list price of $525,000 per unit. The Rochester, N.Y.-based company will collect a fee of $100 per procedure from doctors using the technology.

...